Evidence map›Paper›PMID 16815886›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2006

3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice.

Alexander V Ovechkin, Neetu Tyagi, Utpal Sen, David Lominadze, Mesia M Steed, Karni S Moshal, Suresh C Tyagi

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Homocysteine, Alcoholism, and Its Potential Epigenetic Mechanism.Alcoholism, clinical and experimental research · 2016
    Review
  10. Matrix metalloproteinases in exercise and obesity.Vascular health and risk management · 2016
    Review
  11. Review
  12. Epigenetic regulation of aortic remodeling in hyperhomocysteinemia.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2014
    Article
  13. Article
  14. Review
  15. Article
  16. Mesenteric vascular remodeling in hyperhomocysteinemia.Molecular and cellular biochemistry · 2011
    Article
  17. Article
  18. Review
  19. Article
  20. Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alexander V OvechkinDepartment of Physiology & Biophysics, Health Sciences Center A-1115, School of Medicine, University of Louisville, KY 40202, USA.
Neetu Tyagi
Utpal Sen
David Lominadze
Mesia M Steed
Karni S Moshal
Suresh C Tyagi
University of Louisville · USUniversity of Louisville Hospital · US

Funding

Reversing diabetic muscle myopathy by exercise and exosomesR01HL074185 · NHLBI · UNIVERSITY OF LOUISVILLE · PI TYAGI, SURESH C. · 2003 to 2018
$5.7M
Mechanism of Vascular Remodeling in HyperhomocysteinemiaR01HL071010 · NHLBI · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI TYAGI, SURESH C. · 2002 to 2010
$2.7M
Fibronogen-Induced Vasconstriction during HypertensionR01HL080394 · NHLBI · UNIVERSITY OF LOUISVILLE · PI LOMINADZE, DAVID · 2007 to 2011
$2.1M
NHLBI NIH HHS HL-71010NHLBI NIH HHS HL-74185NHLBI NIH HHS R01 HL071010NHLBI NIH HHS R01 HL074185NHLBI NIH HHS R01 HL080394
6 · The paper itself

Abstract

Chronic hyperhomocysteinemia (HHcy) is an important factor in development of arterial hypertension. HHcy is associated with activation of matrix metalloproteinases (MMPs); however, it is unclear whether HHcy-dependent extracellular matrix (ECM) accumulation plays a role in arterial hypertrophy and hypertension. We tested the hypothesis that in HHcy the mechanism of arterial hypertension involves arterial dysfunction in response to ECM accumulation between endothelial and arterial smooth muscle cells and subsequent endothelium-myocyte (E-M) uncoupling. To decrease plasma Hcy, dietary supplementation with 3-deazaadenosine (DZA), the S-adenosylhomocysteine hydrolase inhibitor, was administered to cystathionine beta-synthase (CBS) knockout (KO) mice. Mice were grouped as follows: wild type (WT; control), WT+DZA, CBSKO, and CBSKO+DZA (n = 4/group). Mean aortic blood pressure and heart rate were monitored in real time with a telemetric system before, during, and after DZA treatment (6 wk total). In vivo aorta function and morphology were analyzed by M-mode and Doppler echocardiography in anesthetized mice. Aorta MMP activity in unfixed cryostat sections was measured with DQ gelatin. Aorta MMP-2, MMP-9, and connexin 43 expression were measured by RT-PCR and Western blot analyses, respectively. HHcy caused increased aortic blood pressure and resistance, tachycardia, and increased wall thickness and ECM accumulation in aortic wall vs. control groups. There was a linear correlation between aortic wall thickness and plasma Hcy levels. MMP-2, MMP-9, and connexin 43 expression were increased in HHcy. In the CBSKO+DZA group, aortic blood pressure and levels of MMP and connexin 43 were close to those found in control groups. However, removal of DZA reversed the aortic lumen-to-wall thickness ratio in CBSKO mice, suggesting, in part, a role of vascular remodeling in the increase in blood pressure in HHcy. The results show that arterial hypertension in HHcy mice is, in part, associated with arterial remodeling and E-M uncoupling in response to MMP activation.

Indexed as

AnimalsAntibiotics, AntineoplasticAortaBlood PressureConnexin 43Cystathionine beta-SynthaseEchocardiographyEndothelium, VascularExtracellular MatrixFemaleHeart RateHomocysteineHyperhomocysteinemiaHypertensionMaleMatrix Metalloproteinase 23-deazaadenosineAntibiotics, AntineoplasticConnexin 43Cystathionine beta-SynthaseHomocysteineMatrix Metalloproteinase 2Matrix Metalloproteinase 9Tubercidin

Identifiers

PMID16815886
PMCPMC3182487
OpenAlexW2103257623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.